Clinical Trials Logo

Pleural Diseases clinical trials

View clinical trials related to Pleural Diseases.

Filter by:

NCT ID: NCT02633332 Completed - Clinical trials for Rheumatoid Arthritis

Use of Well Known Drugs for New Destination - RA Improvement (RANT)

RANT
Start date: February 2015
Phase: Phase 1
Study type: Interventional

The purpose of this interventional study is to determine whether tetracyclines, statins, antiviral and Vitamin D3 in single subministration are effective in improvement of life and health condition in the treatment of rheumatoid arthritis due to autoimmune disease (RA) in all his forms, specially in patients intolerant to commonly used treatments.

NCT ID: NCT02414269 Active, not recruiting - Breast Cancer Clinical Trials

Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin

Start date: May 2015
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this Phase I study is to test the safety of different doses of specially prepared immune cells (called "T cells") collected from blood. The Investigators want to find a safe dose of these modified T cells for patients who have malignant pleural disease. They want to find out what effects these T cells have on the patient and the cancer (MPD). Phase 2 part of the study, the investigators will test the dose in combination with another drug, pembrolizumab, to see what effects the study treatment has on malignant pleural mesothelioma.

NCT ID: NCT02359383 Completed - Infection Clinical Trials

Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion

FISIOPLEURA
Start date: January 2014
Phase: N/A
Study type: Interventional

Chest physiotherapy (CP) facilitates the absorption of fluid in the pleural cavity and reduces the formation of fibrous adhesions in patients with pleural infection, allowing a faster clinical, functional and radiological improve. The aim of the study is to determine if the CP associated with conventional medical treatment (CT) improves functional sequelae secondary to pleural infectious.

NCT ID: NCT01475084 Completed - Pleural Effusion Clinical Trials

Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study

Start date: November 2011
Phase: Phase 2/Phase 3
Study type: Interventional

The purpose of this study is to compare cryobiopsies with forceps biopsies during semirigid thoracoscopy.

NCT ID: NCT01472172 Completed - Pleural Effusion Clinical Trials

Pleural Cryobiopsies During Semirigid Thoracoscopy: A New Technique

Start date: February 2010
Phase: Phase 0
Study type: Interventional

The purpose of this study is to determine feasibility of pleural biopsies with the cryoprobe during semirigid thoracoscopy. The secondary aim is to evaluate safety with focus on bleeding intensity.

NCT ID: NCT01366261 Completed - Pleural Diseases Clinical Trials

Rigid Versus Semirigid Thoracoscopy in Diagnosing Pleural Diseases: a Randomized Study

Start date: January 2008
Phase: Phase 3
Study type: Interventional

The purpose of our study was to compare the size and the quality of biopsy samples together with the diagnostic adequacy of semirigid thoracoscopy with that of rigid instrument in prospective, randomized fashion. The second aim was to compare safety and tolerability of both types of procedure, performed in local anesthesia with addition of intravenous sedation and analgesia.

NCT ID: NCT01356979 Completed - Pleural Diseases Clinical Trials

Outcome of Patients Undiagnosed Under Medical Thoracoscopy

Start date: February 2002
Phase: N/A
Study type: Observational

Medical thoracoscopy (MT) under local anaesthetic and mild sedation, an established method in the diagnosis of pleural diseases. MT has an overall diagnostic yield above 90% for malignant pleural diseases and pleural tuberculosis. However, others who are diagnosed as fibrinous pleuritis make confusion in clinicians. Whether these patients are firmly followed or not ? The investigators do not know the answer of this question. In this study the investigators aimed to investigate the outcome of the patients who are diagnosed as fibrinous pleuritis on MT biopsies.

NCT ID: NCT01246453 Completed - Pleural Effusion Clinical Trials

Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Empyema

Start date: December 2003
Phase: Phase 4
Study type: Interventional

1. Objectives: - Main objective: To evaluate the efficacy and safety of intrapleural alteplase vs urokinase in patients with complex complicated parapneumonic pleural effusion and empyema. - To evaluate the pleural and plasmatic levels of the fibrinolytic system markers after the treatment with alteplase vs urokinase - To evaluate the safety of alteplase in the treatment of complex complicated parapneumonic pleural effusion and empyema 2. Design: Multicentric, randomized, parallel, controlled and double blind 3. Main variable: Percentage of curation 4. Study population and number of patients: 204 patients with complex complicated parapneumonic pleural effusions and empyema 5. Duration of the treatment: Three days (main variable), and optional three days (secondary variable)

NCT ID: NCT01196585 Completed - Pleural Diseases Clinical Trials

Ultrasonography Guided Pleural Biopsy Versus Computed Tomography Guided Pleural Biopsy

Start date: April 2009
Phase: N/A
Study type: Interventional

This study aims to compare the diagnostic efficiency and reliability of Abrams' needle pleural biopsy under computerized tomography guidance with that of cutting-needle pleural biopsy under ultrasonography guidance in patients with pleural effusion.

NCT ID: NCT01193439 Completed - Pleural Diseases Clinical Trials

Safety of Thoracoscopy in Patients With High Risk

Start date: January 2002
Phase: N/A
Study type: Observational

Medical thoracoscopy can be performed for diagnostic as well as therapeutic purposes. Thoracoscopy in the diagnosis of pleural diseases is highly sensitive for detecting pleural neoplasia with negative pleural fluid cytology and in the diagnosis of tuberculosis. The indication of thoracoscopy in patients with pleural effusion has been optimized. In some studies medical thoracoscopy has been claimed a useful diagnostic tool with a very low rate of complications. However the investigators do not know its safety on high risk patients. Because many patients having suspected malignancy have bed conditions due to other health problems such as coronary heart diseases, COPD, arrythmia, hypoxemia. In this study the investigators aimed to test the safety of medical thoracoscopy in the patients with high risk for complications.